Product Images Ipratropium Bromide And Albuterol Sulfate

The text appears to be a mix of random characters and symbols, with a reference to Albuterol and Ipratropium being combined into a solution for inhalation called "mimutoral Sulfote". Without more context, it is difficult to provide a more detailed description.*

This document provides data on adverse events that occurred in over 1% of patients in at least one treatment group, where the combination treatment resulted in the highest percentage. The table shows the number of patients and percentage of patients that experienced adverse events, broken down by body system and specific condition. Adverse events are reported for treatment with Albuterol, Ipratropium, and Ipratropium Bromide.*

This is a description of a relabeled Ipratropium Bromide / Albuterol Sulfate inhalation solution manufactured by Nephron Pharmaceuticals Corporation. It comes in a 15mL package with 5 vials of 3mL each. The solution is for oral inhalation only, and each vial contains 0.5 mg ipratropium bromide and 3 mg albuterol sulfate. It has a product ID of S1005115 and a GTIN of 0371205051150. The relabeling was done by Proficient Rx LP, located in Thousand Oaks, CA. The expiration date is not specified, but it is recommended to store the medication between 2° and 25°C (36° and 77°F) and keep it out of the reach of children.*